Source link : https://www.newshealth.biz/health-news/fda-approves-treosulfan-as-part-of-aml-mds-conditioning-regimen/
The FDA approved treosulfan (Grafapex) with fludarabine as a preparative regimen for allogeneic hematopoietic stem cell transplantation in patients ages 1 year and older with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS), Medexus announced on Wednesday. “This FDA approval provides a useful option for adult and pediatric patients, with the potential to enhance overall […]
Author : News Health
Publish date : 2025-01-22 22:14:01
Copyright for syndicated content belongs to the linked Source.